Trasir Therapeutics is a pioneer in extrahepatic oligonucleotide delivery.
Trasir Therapeutics is a pioneer in extrahepatic oligonucleotide delivery. The company has developed an oligonucleotide delivery platform for delivery of short interfering RNA and other therapeutic RNA payloads to sites outside the liver.